dc.creatorMartínez Torres, Alejandra
dc.creatorMartínez Gaensly, Miguel
dc.date.accessioned2019-01-29T17:50:54Z
dc.date.available2019-01-29T17:50:54Z
dc.date.created2019-01-29T17:50:54Z
dc.date.issued2002
dc.identifierRevista Espanola de Cardiologia, Volumen 55, Issue 6, 2018, Pages 652-656
dc.identifier03008932
dc.identifier10.1016/S0300-8932(02)76673-6
dc.identifierhttps://repositorio.uchile.cl/handle/2250/163459
dc.description.abstractThere is increasing evidence that certain microbial agents may have an etiopathogenic role in the development of atherothrombosis. Helicobacter pylori, a bacterium that causes peptic ulcer disease, has been suggested as one of the microbes involved in the development of atherothrombosis. This hypothesis is based on the following observations: a) a higher prevalence of Helicobacter pylori infection in patients with coronary artery disease, myocardial infarction, or cerebrovascular disease; b) the coincidence of Helicobacter pylori infection and cardiovascular risk factors, such as serum cholesterol and triglyceride concentrations and plasma fibrinogen; c) Helicobacter pylori seropositivity correlates with acute-phase proteins associated with higher risk of coronary disease, such as C-reactive protein, and d) controversial PCR studies indicating the presence of Helicobacter pylori in atheromas. Analysis of the scientific evidence suggests that Helicobacter pylori infection could indirect
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Espanola de Cardiologia
dc.subjectAtherosclerosis
dc.subjectCardiovascular risk factor
dc.subjectCerebrovascular disease
dc.subjectCoronary heart disease
dc.subjectHelicobacter pylori
dc.titleHelicobacter pylori: A new cardiovascuar risk factor?
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución